全文获取类型
收费全文 | 150638篇 |
免费 | 14363篇 |
国内免费 | 7910篇 |
专业分类
耳鼻咽喉 | 1186篇 |
儿科学 | 1461篇 |
妇产科学 | 1863篇 |
基础医学 | 36266篇 |
口腔科学 | 4144篇 |
临床医学 | 11572篇 |
内科学 | 21259篇 |
皮肤病学 | 2478篇 |
神经病学 | 12774篇 |
特种医学 | 4310篇 |
外国民族医学 | 33篇 |
外科学 | 14674篇 |
综合类 | 22145篇 |
现状与发展 | 27篇 |
一般理论 | 2篇 |
预防医学 | 4300篇 |
眼科学 | 4550篇 |
药学 | 14626篇 |
28篇 | |
中国医学 | 5109篇 |
肿瘤学 | 10104篇 |
出版年
2024年 | 311篇 |
2023年 | 1855篇 |
2022年 | 3447篇 |
2021年 | 4813篇 |
2020年 | 4698篇 |
2019年 | 4179篇 |
2018年 | 4292篇 |
2017年 | 4708篇 |
2016年 | 5227篇 |
2015年 | 5846篇 |
2014年 | 9062篇 |
2013年 | 11057篇 |
2012年 | 8593篇 |
2011年 | 9884篇 |
2010年 | 8207篇 |
2009年 | 7876篇 |
2008年 | 8244篇 |
2007年 | 8289篇 |
2006年 | 7725篇 |
2005年 | 6679篇 |
2004年 | 5753篇 |
2003年 | 4860篇 |
2002年 | 3874篇 |
2001年 | 3273篇 |
2000年 | 2809篇 |
1999年 | 2433篇 |
1998年 | 2316篇 |
1997年 | 2164篇 |
1996年 | 1992篇 |
1995年 | 1949篇 |
1994年 | 1738篇 |
1993年 | 1517篇 |
1992年 | 1324篇 |
1991年 | 1286篇 |
1990年 | 1061篇 |
1989年 | 1030篇 |
1988年 | 879篇 |
1987年 | 819篇 |
1986年 | 681篇 |
1985年 | 1005篇 |
1984年 | 876篇 |
1983年 | 593篇 |
1982年 | 774篇 |
1981年 | 646篇 |
1980年 | 509篇 |
1979年 | 462篇 |
1978年 | 354篇 |
1977年 | 282篇 |
1976年 | 258篇 |
1975年 | 105篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
5.
6.
Bortezomib is a novel proteasome inhibitor, which has been successfully used to treat mantle cell lymphoma and multiple myeloma. However, the direct effects of bortezomib on acute promyelocytic leukaemia (APL) have not been fully investigated. In the present study, the WST-8 assay, western blotting, flow cytometry, monodansylcadaverine staining and transmission electron microscopy were performed. It was demonstrated that bortezomib treatment induced a time- and dose-dependent decrease in the viability of NB4 cells. Bortezomib treatment induced cell apoptosis in NB4 cells, as assessed by Annexin V/propidium iodide analysis, and the detection of cleaved caspase-3, cleaved poly(ADP-ribose) polymerase, Bax and Bcl-2 expression. Furthermore, bortezomib treatment induced autophagy in NB4 cells, as indicated by autophagosome formation, p62 degradation, LC3-I to LC3-II conversion and formation of acidic autophagic vacuoles. Notably, autophagy induced by bortezomib was initiated prior to apoptosis. Inhibition of autophagy by knocking down Beclin-1 expression increased bortezomib-induced apoptosis in NB4 cells. Therefore, the present study revealed that the combination of bortezomib and autophagy inhibition may be a potential treatment strategy for APL. 相似文献
7.
Phoebe Hammer Kevin White Stephanie Mengden Vessy Korcheva Philipp W. Raess 《Journal of cutaneous pathology》2019,46(5):343-346
Cutaneous leiomyomas are rare benign smooth‐muscle tumors. These lesions are distinguished based on their cell of origin and are subclassified as pilar leiomyoma, angioleiomyoma, and genital‐type leiomyoma. Nipple leiomyoma is the least common genital‐type leiomyoma, arising from the dartoic muscle cell of the nipple. Histologic examination of the lesion is necessary for definitive diagnosis, and these uncommon tumors can pose a diagnostic challenge. We describe herein a series of six nipple leiomyomas with a spectrum of histologic appearances. 相似文献
8.
9.
目的探究面肌痉挛患者微血管减压术(MVD)中异常肌反应(AMR)的变化特点与术后疗效的关系。方法回顾性分析73例MVD术中采用AMR全程定量化监测患者的AMR变化特点,减压操作前AMR阈值较基础阈值升高≥1倍为A1组、1倍为A2组,手术结束时AMR完全消失为B1组、未消失为B2组,B2组中AMR阈值较基础阈值升高≥1倍为B2a组、1倍为B2b组,对各组的术后疗效进行对比分析。结果 A1组21例中,19例立即治愈,1例延迟治愈,1例未愈; A2组52例中,35例立即治愈,9例延迟治愈,8例未愈。A1组较A2组疗效好(P=0. 046)。B1组50例中,42例立即治愈,5例延迟治愈,3例未愈; B2组23例中,12例立即治愈,5例延迟治愈,6例未愈。B1组较B2组疗效好(P=0. 003)。B2 a组的治愈比例较B2 b组高(分别为14/16、3/7),差异有统计学意义(P=0. 045)。结论 AMR在术中的变化特点对术者有重要参考意义,AMR在减压前升高、在手术结束时完全消失、未消失但升高较基础阈值≥1倍者术后疗效相对较好。 相似文献
10.
Gut bacteria and gut barrier plays important roles in body homeostasis. Ciprofloxacin (CPFX) is widely used to treat bacterial infections. However, whether high dosage of CPFX has side effects on gut barrier integrity is still unclear. Our results indicated that the High CPFX treatment (1 mg/ml) caused weight loss, nervousness, anorexia, and increased apoptosis cells in gut, but less influence was observed in the Low CPFX group (0.2 mg/ml). Meanwhile, the High CPFX treatment impaired tight junction molecules Ocln/ZO-1 level and down-regulated antibacterial genes expression (reg3γ, pla2g2α and defb1). Further, the High CPFX treatment increased pro-inflammatory cytokine IL-1β in intestinal tract, decreased IL-17A of duodenum but increased IL-17A of colon at day 37. In addition, the gut bacterial diversity and richness behaved significantly loss regarding CPFX treatment, especially in the High CPFX group during the experiment. Indole exhibited sharply decline in both Low and High CPFX groups at day 7, and the High CPFX mice needed longer time on restoring indole level. Meanwhile, CPFX treatment strongly decreased the concentrations of butyric acid and valeric acid at day 1. Correlation analysis indicated that the linked patterns between the key bacteria (families Bacteroidales_S247, Ruminococcaceae and Desulfovibrionaceae) and metabolites (indole and butyric acid) were disturbed via the CPFX treatment. In conclusion, the High CPFX treatment impaired the gut barrier with the evidence of reduced expression of tight junction proteins, increased apoptosis cells and inflammatory cells, decreased the bacterial diversity and composition, which suggesting a proper antibiotic-dosage use should be carefully considered in disease treatment. 相似文献